Novartis Q4 core operating income gains 9%

Novartis forecast its
sales and core operating profit would grow at a mid-single-digit
rate this year, as the Swiss pharmaceuticals group nears a
decision on whether to keep or sell its generics... | February 2, 2022

Related Keywords

Switzerland ,Swiss ,Michael Shields ,Ludwig Burger ,Novartis ,Novartis Ag Stock Exchange ,News ,Information ,Press Release ,Forecast ,End ,More ,Operating ,Profit ,Would ,Row ,It ,This ,Us ,The ,Pharmaceuticals ,Group ,Tears ,N ,Whether ,O ,Jeep ,Dr ,Fell ,Ts Novn Ch0012005267 ,